Cargando…
Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages
Type 1 diabetes (T1D) is an autoimmune disease caused by the selective destruction of the pancreatic β-cells, causing inability to produce insulin. Proinflammatory cytokines such as IL-1β, IL-6, TNF-α, IFN-γ, IL-12, IL-17, and NO can be released by CD4 and CD8(+) lymphocytes as well as by classicall...
Autores principales: | Espinoza-Jiménez, Arlett, De Haro, Roberto, Terrazas, Luis I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698814/ https://www.ncbi.nlm.nih.gov/pubmed/29249872 http://dx.doi.org/10.1155/2017/8074329 |
Ejemplares similares
-
Immunoregulation by Taenia crassiceps and Its Antigens
por: Peón, Alberto N., et al.
Publicado: (2013) -
Taenia crassiceps Infection Attenuates Multiple Low-Dose Streptozotocin-Induced Diabetes
por: Espinoza-Jiménez, Arlett, et al.
Publicado: (2010) -
Taenia crassiceps Infection Does Not Influence the Development of Experimental Rheumatoid Arthritis
por: Ortiz-Flores, Aaxin M., et al.
Publicado: (2013) -
Alternatively Activated Macrophages in Types 1 and 2 Diabetes
por: Espinoza-Jiménez, Arlett, et al.
Publicado: (2012) -
The Macrophage Galactose-Type Lectin-1 (MGL1) Recognizes Taenia crassiceps Antigens, Triggers Intracellular Signaling, and Is Critical for Resistance to This Infection
por: Montero-Barrera, Daniel, et al.
Publicado: (2015)